Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127640971 | 12764097 | 1 | I | 20160820 | 20160912 | 20160920 | 20160920 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-075859 | BRISTOL MYERS SQUIBB | 71.43 | YR | F | Y | 0.00000 | 20160920 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127640971 | 12764097 | 1 | PS | HYDREA | HYDROXYUREA | 1 | Oral | 1 DF, QD | 16295 | 1 | DF | CAPSULE, HARD | QD | ||||||
| 127640971 | 12764097 | 2 | SS | XELODA | CAPECITABINE | 1 | Unknown | 2 TAB, QD | 24 | DF | 0 | 2 | DF | TABLET | QD | ||||
| 127640971 | 12764097 | 3 | C | TEMERIT | NEBIVOLOL | 1 | Unknown | 5 MG, UNK | U | 0 | 5 | MG | |||||||
| 127640971 | 12764097 | 4 | C | TARDYFERON | FERROUS SULFATE | 1 | Unknown | U | 0 | ||||||||||
| 127640971 | 12764097 | 5 | C | COAPROVEL | HYDROCHLOROTHIAZIDEIRBESARTAN | 1 | Unknown | 1 DF, UNK | U | 0 | 1 | DF | |||||||
| 127640971 | 12764097 | 6 | C | ESOMEPRAZOLE | ESOMEPRAZOLE | 1 | Unknown | 40 MG, UNK | U | 0 | 40 | MG | |||||||
| 127640971 | 12764097 | 7 | C | ESBERIVEN FORT | MELILOTUS OFFICINALIS TOPRUTIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 127640971 | 12764097 | 8 | C | TILCOTIL | TENOXICAM | 1 | Unknown | 20 MG, UNK | U | 0 | 20 | MG | |||||||
| 127640971 | 12764097 | 9 | C | KARDEGIC | ASPIRIN LYSINE | 1 | Unknown | 75 MG, UNK | U | 0 | 75 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127640971 | 12764097 | 1 | Thrombocytopenia |
| 127640971 | 12764097 | 2 | Colorectal adenocarcinoma |
| 127640971 | 12764097 | 3 | Product used for unknown indication |
| 127640971 | 12764097 | 4 | Product used for unknown indication |
| 127640971 | 12764097 | 5 | Product used for unknown indication |
| 127640971 | 12764097 | 6 | Product used for unknown indication |
| 127640971 | 12764097 | 7 | Product used for unknown indication |
| 127640971 | 12764097 | 8 | Product used for unknown indication |
| 127640971 | 12764097 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127640971 | 12764097 | HO |
| 127640971 | 12764097 | LT |
| 127640971 | 12764097 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127640971 | 12764097 | Agranulocytosis | |
| 127640971 | 12764097 | Anaemia | |
| 127640971 | 12764097 | Bone marrow failure | |
| 127640971 | 12764097 | Cancer surgery | |
| 127640971 | 12764097 | Failure to anastomose | |
| 127640971 | 12764097 | Packed red blood cell transfusion | |
| 127640971 | 12764097 | Peritonitis | |
| 127640971 | 12764097 | Platelet transfusion | |
| 127640971 | 12764097 | Pneumoperitoneum | |
| 127640971 | 12764097 | Product use issue | |
| 127640971 | 12764097 | Shock | |
| 127640971 | 12764097 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127640971 | 12764097 | 1 | 201512 | 20160816 | 0 | |
| 127640971 | 12764097 | 2 | 20160805 | 20160816 | 0 |